Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Manufacturing & engineering

BioLargo appoints accomplished business executives Linda Park and Christina Bray to its board of directors

Both new board members have a background, education, and corporate experience that make them an ideal fit to advance BioLargo's core organizational goals, and its vision to "make life better" through its cleantech products and services.

BioLargo Inc (OTCQB:BLGO) announced that it has appointed Linda Park and Christina Bray to the company’s board of directors.

The developer of technologies in the cleantech space said Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies, while Bray is a senior finance specialist, entrepreneur, and renewables specialist, who is currently the CEO of Bluedot Energies, a company that designs, builds, and manages electric vehicle charging stations for large-scale public and private applications.

“Both (Park and Bray) have such significant experience in advancing innovative projects, as well as building and supporting successful companies,” BioLargo CEO Dennis Calvert said in a statement.

READ: BioLargo eyeing commercial opportunities ahead as it sets new quarterly revenue record

“We know that they will make important contributions to our efforts to transform BioLargo into a cleantech juggernaut,” Calvert added.

BioLargo also noted that the new board members will replace John Runyan and Kent (Rick) Roberts II, who have retired from their board positions, although both will remain as formal advisors to the company’s board of directors as their time permits.

BioLargo invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control.

With over 13 years of extensive R&D, it also holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK